NASDAQ:BDTX | Free Cash Flow | Black Diamond Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$10.23M
2025-12-31-$6.79M
2025-03-31$53.41M
2024-12-31-$15.06M$0.00-$15.06M
2024-03-31-$21.2M
2023-12-31-$13.96M$0.00-$13.96M
2023-03-31-$20.03M$0.00-$20.03M
2022-12-31-$21.94M$0.00-$21.94M
2022-03-31-$28.6M$7,000.00-$28.61M
2021-12-31-$24.05M$333,000.00-$24.38M
2021-03-31-$24.46M$40,000.00-$24.5M
2020-12-31-$15.77M$109,000.00-$15.88M
2020-03-31-$11.32M$0.00-$11.32M
2019-12-31-$7.49M$2,000.00-$7.49M
2019-03-31-$6.88M$10,000.00-$6.89M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$29.61M
2024-12-31-$62.3M$0.00-$62.3M
2023-12-31-$66.72M$33,000.00-$66.75M
2022-12-31-$85.08M$192,000.00-$85.27M
2021-12-31-$100.15M$2.71M-$102.86M
2020-12-31-$52.15M$142,000.00-$52.29M
2019-12-31-$24.67M$21,000.00-$24.7M
2018-12-31-$8.45M$76,000.00-$8.53M